Anavex Life Sciences Corp (AVXL)

[falconer66a]

Early Revelation of Anavex 2-73 Rett Efficacy

If Anavex 2-73 yields any level of symptomatic improvement in little Rett girls, those favorable treatment outcomes will not be subtle, discerned only with biochemical analyses by medical technicians. Check out the symptoms of Rett syndrome, here:

https://www.mayoclinic.org/diseases-conditions/rett-syndrome/symptoms-causes/syc-20377227

Which of these will be hard for a non-medical person to quickly detect an improvement in?

Anavex 2-73 efficacy against Rett syndrome may be discovered early in the clinical trial; by both medical people and professional care-givers, and especially by family members.

Mothers know precisely the status of their children’s health. Any improvements, such as improved movement and coordination, increased communication skills, reduction in aberrant hand movements, normalized eye control, reduction in breathing problems, reduced irritability or crying, improved cognition, reduced frequencies or severities of seizures, improved sleep patterns, (and others), will be easily detected and noted. The required blindedness of the clinical trial (where no one, patients, medical people, staff, etc. knows what patients are getting a starch pill or the actual drug) will not be sufficient to keep any positive clinical outcomes unrevealed before the trial ends.

With any sort of even moderate treatment efficacies, stories will be told. Knowing how drug trials are to be blinded to all, just who would share those stories when first discovered? Mothers and nurses are typically silent, keeping health observations to themselves, right? Ha.